The Antarctic psychrophile, Chlamydomonas subcaudata, is deficient in state I-state II transitions.
State I-State II transitions were monitored in vivo and in vitro in the Antarctic, psychrophillic, green alga, Chlamydomonas subcaudata, as changes in the low-temperature (77 K) chlorophyll fluorescence emission maxima at 722 nm (F722) relative to 699 nm (F699). As expected, the control mesophillic species, Chlamydomonas reinhardtii, was able to modulate the light energy distribution between photosystem II and photosystem I in response to exposure to four different conditions: (i) dark/anaerobic conditions, (ii) a change in Mg2+ concentration, (iii) red light, and (iv) increased incubation temperature. This was correlated with the ability to phosphorylate both of its major light-harvesting polypeptides. In contrast, exposure of C. subcaudata to the same four conditions induced minimum alterations in the 77 K fluorescence emission spectra, which was correlated with the ability to phosphorylate only one of its major light-harvesting polypeptides. Thus, C. subcaudata appears to be deficient in the ability to undergo a State I-State II transition. Functionally, this is associated with alterations in the apparent redox status of the intersystem electron transport chain and with higher rates of photosystem I cyclic electron transport in the psychrophile than in the mesophile, based on in vivo P700 measurements. Structurally, this deficiency is associated with reduced levels of Psa A/B relative to D1, the absence of specific photosystem I light-harvesting polypeptides [R.M. Morgan et al. (1998) Photosynth Res 56:303-314] and a cytochrome b6/f complex that exhibits a form of cytochrome f that is approximately 7 kDa smaller than that observed in C. reinhardtii. We conclude that the Antarctic psychrophile, C. subcaudata, is an example of a natural variant deficient in State I-State II transitions.
Morgan-Kiss
Rachael M
RM
The Department of Plant Sciences, The University of Western Ontario, London, Canada.
Ivanov
Alexander G
AG
Huner
Norman P A
NP
D020418:Algal Proteins / Q000187:drug effects / Q000378:metabolism / Q000528:radiation effects; D000693:Anaerobiosis; D000818:Animals; D000864:Antarctic Regions; D002696:Chlamydomonas / Q000187:drug effects / Q000502:physiology* / Q000528:radiation effects; D002734:Chlorophyll / Q000378:metabolism / Q000528:radiation effects; D003080:Cold Temperature; D003991:Dibromothymoquinone / Q000494:pharmacology; D004237:Diuron / Q000494:pharmacology; D004579:Electron Transport; D004591:Electrophoresis, Polyacrylamide Gel; D005453:Fluorescence; D015151:Immunoblotting; D008027:Light; D008274:Magnesium / Q000494:pharmacology; D008627:Mercuric Chloride / Q000494:pharmacology; D010084:Oxidation-Reduction; D010788:Photosynthesis / Q000187:drug effects / Q000502:physiology* / Q000528:radiation effects; D020524:Thylakoids / Q000187:drug effects / Q000378:metabolism / Q000528:radiation effects
D020418:Algal Proteins; D002734:Chlorophyll; D003991:Dibromothymoquinone; D008627:Mercuric Chloride; D004237:Diuron; D008274:Magnesium